Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

2.

Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.

Dajani EZ, Islam K.

J Physiol Pharmacol. 2008 Aug;59 Suppl 2:117-33. Review.

PMID:
18812633
3.

Prostaglandins and brain-gut axis.

Dajani EZ, Shahwan TG, Dajani NE.

J Physiol Pharmacol. 2003 Dec;54 Suppl 4:155-64. Review.

4.

Statins, platelet aggregation and coronary heart disease.

Dajani EZ, Shahwan TG, Dajani NE.

J Assoc Acad Minor Phys. 2002 Jan;13(1):27-31. Review.

PMID:
11852668
5.

Highlights of the 14th Annual Scientific Meeting of the Association for Academic Minority Physicians, 2000.

Trotman BW, Boyce JG, Dajani EZ, Davidson EC Jr, Scott VF.

J Assoc Acad Minor Phys. 2001 Mar;12(1-2):95-7. No abstract available.

PMID:
11851198
6.

Novel therapeutic approaches to gastric and duodenal ulcers: an update.

Dajani EZ, Klamut MJ.

Expert Opin Investig Drugs. 2000 Jul;9(7):1537-44. Review.

PMID:
11060758
7.

Selective COX-2 inhibitors and gastrointestinal mucosal injury: pharmacological and therapeutic considerations.

Dajani EZ, Agrawal NM.

J Assoc Acad Minor Phys. 2000;11(2-3):28-31. Review.

PMID:
10953541
8.

Gastroesophageal reflux disease: pathophysiology and pharmacology overview.

Dajani EZ.

J Assoc Acad Minor Phys. 2000;11(1):7-11.

PMID:
10826019
9.

Highlights of the 13th annual scientific meeting of the Association for Academic Minority Physicians, 1999

Boyce JG, Dajani EZ, Kamholz SL, Rayford PL, Scott VF.

J Assoc Acad Minor Phys. 2000;11(1):3-5. No abstract available.

PMID:
10826018
10.

1',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties.

Dajani EZ, Larsen KR, Taylor J, Dajani NE, Shahwan TG, Neeleman SD, Taylor MS, Dayton MT, Mir GN.

J Pharmacol Exp Ther. 1999 Oct;291(1):31-8.

PMID:
10490883
11.

Idiopathic esophageal ulceration in acquired immunodeficiency syndrome: successful treatment with misoprostol and viscous lidocaine.

Adeoti AG, Vega KJ, Dajani EZ, Trotman BW, Kloser PC.

Am J Gastroenterol. 1998 Nov;93(11):2069-74.

PMID:
9820375
12.

Effects of tolcapone, a catechol-O-methyltransferase inhibitor, and Sinemet on intestinal electrolyte and fluid transport in conscious dogs.

Larsen KR, Dajani EZ, Dajani NE, Dayton MT, Moore JG.

Dig Dis Sci. 1998 Aug;43(8):1806-13.

PMID:
9724173
13.

Gastrointestinal toxicity of over-the-counter analgesics.

Dajani EZ.

Am J Gastroenterol. 1998 Jul;93(7):1020-2. No abstract available.

PMID:
9672322
14.

Systemic treatment with epidermal growth factor in pigs induces ductal proliferations in the pancreas.

Vinter-Jensen L, Juhl CO, Teglbjaerg PS, Poulsen SS, Dajani EZ, Nexø E.

Gastroenterology. 1997 Oct;113(4):1367-74.

PMID:
9322532
15.
16.

The effect of epidermal growth factor on circulating levels of IGF and IGF-binding proteins in adult Goettingen minipigs.

Vinter-Jensen L, Juhl CO, Frystyk J, Dajani EZ, Oksbjerg N, Flyvbjerg A.

J Endocrinol. 1996 Dec;151(3):401-7.

PMID:
8994385
17.

Prostaglandins, NSAIDS, and GI mucosal integrity: can we identify patients at risk of NSAID-induced gastric injury?

Dajani EZ.

Am J Gastroenterol. 1996 May;91(5):835-6. No abstract available.

PMID:
8633566
18.

Idiopathic esophageal ulceration in patients infected with human immunodeficiency virus.

Vega KJ, Bollu J, Dajani EZ, Trotman BW.

J Assoc Acad Minor Phys. 1996;7(4):93-8. Review.

PMID:
8936935
19.

Impedance planimetric characterization of the distal oesophagus in the Goettingen minipig.

Gregersen H, Vinter-Jensen L, Juhl CO, Dajani EZ.

J Biomech. 1996 Jan;29(1):63-8.

PMID:
8839018
20.

Chronic administration of epidermal growth factor to pigs induces growth, especially of the urinary tract with accumulation of epithelial glycoconjugates.

Vinter-Jensen L, Juhl CO, Poulsen SS, Djurhuus JC, Dajani EZ, Nexø E.

Lab Invest. 1995 Dec;73(6):788-93.

PMID:
8558839
21.

Chronic treatment with epidermal growth factor causes esophageal epithelial hyperplasia in pigs and rats.

Juhl CO, Vinter-Jensen L, Poulsen SS, Orntoft TF, Dajani EZ.

Dig Dis Sci. 1995 Dec;40(12):2717-23.

PMID:
8536536
22.

Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates.

Vinter-Jensen L, Juhl CO, Djurhuus JC, Poulsen SS, Dajani EZ, Brown KD, Orntoft TF, Teglbjaerg PS, Nexø E.

Am J Pathol. 1995 Nov;147(5):1330-8.

23.

Systemic treatment with epidermal growth factor induces anaemia in Goettingen minipigs.

Juhl CO, Vinter-Jensen L, Myhre-Jensen O, Jensen LS, Dajani EZ.

Clin Sci (Lond). 1995 Oct;89(4):453-8.

PMID:
7493447
24.

Preventive effects of recombinant human epidermal growth factor on the oesophageal epithelium in pigs subjected to sclerotherapy.

Juhl CO, Vinter-Jensen L, Jensen LS, Dajani EZ.

Eur J Gastroenterol Hepatol. 1995 Sep;7(9):823-8.

PMID:
8574712
25.

Epidermal growth factor attenuates the sclerotherapy-induced biomechanical properties of the oesophagus. An experimental study in minipigs.

Vinter-Jensen L, Juhl CO, Eika B, Gregersen H, Dajani EZ.

Scand J Gastroenterol. 1995 Jul;30(7):614-9.

PMID:
7481521
26.

Chronic systemic treatment with epidermal growth factor induces hypergastrinaemia in Goettingen minipigs.

Vinter-Jensen L, Juhl CO, Rehfeld JF, Poulsen SS, Dajani EZ, Nexø E.

Scand J Gastroenterol. 1995 May;30(5):422-7.

PMID:
7638566
27.

Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.

Dajani EZ, Agrawal NM.

J Physiol Pharmacol. 1995 Mar;46(1):3-16. Review.

PMID:
7599335
28.

Ureteric growth in a Goettingen minipig induced by epidermal growth factor. A case report.

Vinter-Jensen L, Juhl CO, Djurhuus JC, Dajani EZ, Teglbjaerg PS, Uvelius B, Nexø E.

Scand J Urol Nephrol Suppl. 1995;172:109-15.

PMID:
8578247
29.

Tissue distribution of 131I-labelled epidermal growth factor in the pig visualized by dynamic scintigraphy.

Vinter-Jensen L, Frøkiaer J, Jørgensen PE, Marqversen J, Rehling M, Dajani EZ, Nexø E.

J Endocrinol. 1995 Jan;144(1):5-12.

PMID:
7891025
31.
32.

Biomechanical properties of the oesophagus damaged by endoscopic sclerotherapy. An impedance planimetric study in minipigs.

Juhl CO, Vinter-Jensen L, Djurhuus JC, Gregersen H, Dajani EZ.

Scand J Gastroenterol. 1994 Oct;29(10):867-73.

PMID:
7839091
33.

Omega-3 fatty acids and bowel cancer.

Dajani EZ.

Gastroenterology. 1993 Apr;104(4):1239-41. No abstract available.

PMID:
8462820
34.

Future treatment of peptic ulcer: is there room for anti-infective drugs?

Dajani EZ.

J Physiol Pharmacol. 1993 Mar;44(1):3-6. Review.

PMID:
8518423
36.

Update on acid-peptic disorders.

Dajani EZ, Straus EW.

J Assoc Acad Minor Phys. 1992;3(3):69. No abstract available.

PMID:
1498524
37.

Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs.

Agrawal NM, Dajani EZ.

J Assoc Acad Minor Phys. 1992;3(4):142-8. Review.

PMID:
1392409
38.

Refractory peptic ulcers.

Arakawa T, Kobayashi K, Dajani EZ.

J Assoc Acad Minor Phys. 1992;3(3):95-102.

PMID:
1386767
39.

Drugs for treatment of peptic ulcers.

Dajani EZ, Trotman BW.

J Assoc Acad Minor Phys. 1992;3(3):78-88. Review.

PMID:
1353999
40.

Misoprostol but not antacid prevents endotoxin-induced gastric mucosal injury: role of tumor necrosis factor-alpha.

Mahatma M, Agrawal N, Dajani EZ, Nelson S, Nakamura C, Sitton J.

Dig Dis Sci. 1991 Nov;36(11):1562-8.

PMID:
1935494
41.

Prostaglandins: an overview of the worldwide clinical experience.

Dajani EZ, Wilson DE, Agrawal NM.

J Assoc Acad Minor Phys. 1991;2(1):23, 27-35. Review.

PMID:
1811816
42.

Misoprostol and dalargin for the inpatient treatment of duodenal ulcer in the USSR.

Dajani EZ, Penin VA, Sokolov LK, Vahtangishvilli R, Bogdanov A, Afonskaya N, Ivanishvilli L, Zharova Y, Efremova I.

J Assoc Acad Minor Phys. 1991;2(1):18-22.

PMID:
1811815
43.

Nonsteroidal anti-inflammatory drugs and acute upper gastrointestinal bleeding: a prospective study.

Agrawal NM, Patel R, Mahatma M, Dajani EZ.

J Assoc Acad Minor Phys. 1991;2(2):64-6.

PMID:
1810582
44.

Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage.

Agrawal NM, Dajani EZ.

J Rheumatol Suppl. 1990 Feb;20:7-11. Review.

PMID:
1969964
45.

Mucosal defense and concept of cytoprotection.

Dajani EZ.

Mod Pathol. 1990 Jan;3(1):3-4. No abstract available.

PMID:
2308918
46.
47.

Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury.

Agrawal NM, Dajani EZ.

Int J Clin Pharmacol Res. 1989;9(6):347-57. Review.

PMID:
2576801
48.

Dose-response, meal-stimulated gastric antisecretory study of prostaglandin E1 analog, misoprostol, in man.

Davis GR, Fordtran JS, Dajani EZ.

Dig Dis Sci. 1988 Mar;33(3):298-302.

PMID:
3125026
49.

Misoprostol attenuates aspirin-induced changes in potential difference and associated damage in canine gastric mucosa.

Gullikson GW, Anglin CP, Kessler LK, Smeach S, Bauer RF, Dajani EZ.

Clin Invest Med. 1987 May;10(3):145-51.

PMID:
3113798
50.

Perspective on the gastric antisecretory effects of misoprostol in man.

Dajani EZ.

Prostaglandins. 1987;33 Suppl:68-77.

PMID:
3122277

Supplemental Content

Loading ...
Support Center